SXTC
China SXT Pharmaceuticals Inc
NASDAQ: SXTC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.06
+0.49% today
Updated 2026-04-30
Market cap
$2.00M
P/E ratio
—
P/S ratio
1.30x
EPS (TTM)
$-57.15
Dividend yield
—
52W range
$1 – $368
Volume
0.1M
WallStSmart proprietary scores
38
out of 100
Grade: D
Sell
Investment rating
4.7
Growth
C5.0
Quality
C+2.5
Profitability
F5.3
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
$2.61
Margin of safety
+4.60%
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-495089.00
- Revenue declining -24.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.60M | $1.97M | $1.93M | $1.74M | $1.54M |
| Net income | $-5.74M | $-5.93M | $-3.10M | $-3.30M | $-1.25M |
| EPS | — | — | — | — | $-57.15 |
| Free cash flow | $205803.00 | $-151441.00 | $-1.94M | $-2.35M | $-495089.00 |
| Profit margin | -220.43% | -301.00% | -160.67% | -189.77% | — |
Peer comparison
Smart narrative
China SXT Pharmaceuticals Inc trades at $2.06. Our Smart Value Score of 38/100 indicates the stock is weak. TTM revenue stands at $1.54M. Our DCF model estimates intrinsic value at $2.61.
Frequently asked questions
What is China SXT Pharmaceuticals Inc's stock price?
China SXT Pharmaceuticals Inc (SXTC) trades at $2.06.
Is China SXT Pharmaceuticals Inc overvalued?
Smart Value Score 38/100 (Grade D, Sell). DCF value $2.61.
What is the price target of China SXT Pharmaceuticals Inc (SXTC)?
The analyst target price is $—, representing NaN% downside from the current price of $2.06.
What is the intrinsic value of China SXT Pharmaceuticals Inc (SXTC)?
Based on our DCF model, intrinsic value is $2.61, a +4.6% margin of safety versus $2.06.
What is China SXT Pharmaceuticals Inc's revenue?
TTM revenue is $1.54M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryChina
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.30x
ROE-50.30%
Beta1.75
50D MA$1.98
200D MA$145.68
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—